Seres Therapeutics Shares Outstanding 2013-2021 | MCRB

Seres Therapeutics shares outstanding from 2013 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Seres Therapeutics Annual Shares Outstanding
(Millions of Shares)
2020 80
2019 57
2018 41
2017 40
2016 40
2015 24
2014 7
2013 6
2012 6
Seres Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 92
2021-03-31 92
2020-12-31 80
2020-09-30 84
2020-06-30 73
2020-03-31 71
2019-12-31 57
2019-09-30 70
2019-06-30 45
2019-03-31 41
2018-12-31 41
2018-09-30 41
2018-06-30 41
2018-03-31 41
2017-12-31 40
2017-09-30 40
2017-06-30 40
2017-03-31 40
2016-12-31 40
2016-09-30 40
2016-06-30 40
2016-03-31 39
2015-12-31 24
2015-09-30 39
2015-06-30 9
2015-03-31 7
2014-12-31 7
2014-09-30 7
2014-06-30 7
2014-03-31 7
2013-12-31
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.657B $0.033B
Seres Therapeutics, Inc. offers microbiome therapeutics platform. It is focused on developing Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. Seres Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29